top of page

Synterex Blog
Featured Blogs
Search


Good Machine Learning Practices (GMLP): Extending GxP Principles in AI-Enabled Healthcare
The integration of artificial intelligence (AI) and machine learning (ML) in healthcare has transformed how medical technology is developed, evaluated, and deployed. This innovation calls for adherence to rigorous quality standards to ensure safety, efficacy, and compliance. While traditional Good Practice (GxP) guidelines—such as Good Manufacturing Practice (GMP), Good Clinical Practice (GCP), and Good Laboratory Practice.

Jeanette Towles
Jan 21


Designing an Audit Trail for AI in Clinical Trials: Aligning with the EU AI Act
As artificial intelligence (AI) continues to transform clinical trials, ensuring transparency, accountability, and compliance has become critical. Central to achieving these goals is the implementation of a robust audit trail system.

Jeanette Towles
Jan 21


Engaging with the FDA on AI in Clinical Trials: Beyond Traditional Meetings
The U.S. Food and Drug Administration's (FDA) draft guidance, Considerations for the Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products, offers a comprehensive framework for the integration of artificial intelligence (AI) in drug development. For regulatory professionals, understanding the various engagement options beyond traditional FDA meetings is crucial for effectively navigating AI applications in clinical trials.

Jeanette Towles
Jan 17


Who's Afraid of the Big, Bad EU AI Act?
The European Union’s Artificial Intelligence Act (EU AI Act) has become a significant milestone in the global regulation of artificial intelligence. As the world’s first comprehensive AI regulation, it introduces a risk-based framework designed to ensure the safe and ethical deployment of AI technologies. For industries relying heavily on innovation, like biopharma clinical trials, understanding this regulation is crucial.

Jeanette Towles
Jan 17


Data Governance Under the EU AI Act: From Clinical Trial Analytics to Compliance
In clinical trials and healthcare, data comprise the foundation of every decision, from designing study protocols to analyzing patient outcomes. As artificial intelligence (AI) increasingly shapes clinical operations, data governance has become a critical factor in ensuring data quality, compliance, and ethical AI deployment. Data governance involves the management of data availability, usability, integrity, and

Jeanette Towles
Jan 17


Building a Compliant Quality Management System for AI in Healthcare
In healthcare and biopharma, ensuring patient safety, product quality, and regulatory compliance has always been paramount. A Quality Management System (QMS) serves as the backbone for these priorities, providing a structured framework for risk management, process standardization, and continuous improvement.

Jeanette Towles
Jan 16
bottom of page








